Journal
BRAZILIAN JOURNAL OF MICROBIOLOGY
Volume 42, Issue 4, Pages 1300-1307Publisher
SPRINGER
DOI: 10.1590/S1517-83822011000400009
Keywords
Vulvovaginal candidiasis; antifungal susceptibility testing; antifungal agents; Candida albicans
Categories
Funding
- University of Cuiaba
- FAPEMAT - Fundacao de Amparo a Pesquisa no Estado de Mato Grosso
- Support of Science of the State of Mato Grosso
Ask authors/readers for more resources
Causative agent in majority of VVC is Candida albicans, but infection due to non-C. albicans is common. Use of empiric antifungal therapy in Brazil due to syndromic management of vulvovaginitis could act as risk factor for increase resistance among VVC causative agents. From Mato Grosso patients, 160 with culture-proved among 404 women who had clinical symptoms of VVC, were enrolled in this study. 70 non-pregnant women and 90 pregnant women were included. Candida albicans was the most prevalent, representing 72.9% in the non-pregnant group and 92.3% in the pregnant group. Differences in species distribution were noted between the two groups, being C. parapsilosis the second more prevalent species among non-pregnant women. Susceptibility testing revealed high susceptibility to fluconazole (except for C. krusei), itraconazole, ketoconazole, and amphotericin B regardless the species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei) analyzed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available